Pfizer's Trading Volume Plummets 89.3% to $984 Million, Ranking 69th as Stock Drops 0.53%

On March 24, 2025, Pfizer's trading volume reached $984 million, marking an 89.3% decrease from the previous day. This placed Pfizer at the 69th position in terms of trading volume for the day. The stock price of Pfizer (PFE) decreased by 0.53%.

Pfizer has exited its stake in Haleon after selling its entire shareholding, generating approximately $3.24 billion from the transaction. This move is part of Pfizer's strategic shift away from consumer healthcare, allowing the company to focus more on its core pharmaceutical and biotechnology businesses.

Pfizer's stock price is currently trading at $25.98, with an average 12-month price target of $31.00. This indicates a potential upside for investors, as the stock is currently trading below its target price. The company's strong pipeline of innovative drugs and vaccines continues to drive investor interest and confidence in its future growth prospects.